(The Consortium of Investigators of Modifiers of BRCA1/2)

Study Groups:

Acronym Study Country
BCFR Breast Cancer Family Registry USA/Australia/Canada
BFBOCC Baltic Familial Breast Ovarian Cancer Consortium Latvia/Lithuania
BIDMC Beth Israel Deaconess Medical Center USA
BMBSA BRCA-gene mutations and breast cancer in South African women South Africa
BRICOH Beckman Research Institute of the City of Hope USA
CBCS Rigshospitalet Denmark
CEMIC CEMIC-Breast Cancer Genes Variants in South America Argentina
CNIO Spanish National Cancer Centre Spain
COH City of Hope Cancer Center USA
CONSIT TEAM CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella Italy
DEMOKRITOS National Centre for Scientific Research Demokritos Greece
DFCI Dana Farber Cancer Institute USA
DKFZ German Cancer Research Center Germany/Pakistan/Colombia
EMBRACE Epidemiological Study of Familial Breast Cancer UK
FCCC Fox Chase Cancer Center USA
FIMR Feinstein Institute for Medical Research USA
FPGMX Fundación Pública Galega de Medicina Xenómica Spain
G-FAST Ghent University Hospital Belgium
GC-HBOC German Familial Breast Group Germany
GEMO Genetic Modifiers of cancer risk in BRCA1/2 mutation carriers France/USA
GEORGETOWN Georgetown University USA
GOG Gynecologic Oncology Group USA
HCSC Hospital Clinico San Carlos Spain
HEBCS Helsinki Breast Cancer Study Finland
HEBON Genen Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland Netherlands
HRBCP Study of Genetic Mutations in Breast and Ovarian Cancer patients in Hong Kong and Asia Hong Kong
HUNBOCS Molecular Genetic Studies of Breast- and Ovarian Cancer in Hungary Hungary
HVH University Hospital Vall d'Hebron Spain
ICARE Inherited CAncer REgistry USA
ICO Institut Català d'Oncologia Spain
IHCC International Hereditary Cancer Centre Poland
ILUH Iceland Landspitali - University Hospital Iceland
INHERIT INterdisciplinary HEalth Research Internal Team BReast CAncer susceptibility Canada (Quebec)
IOVHBOCS Istituto Oncologico Veneto Italy
IPOBCS Portuguese Oncology Institute-Porto Breast Cancer Study Portugal
KCONFAB Kathleen Cuningham Consortium for Research into Familial Breast Cancer Australia/New Zealand
KOHBRA Korean Hereditary Breast Cancer Study Korea
KUMC University of Kansas Medical Center USA
MAGIC Modifiers and Genetics in Cancer USA
MCGILL McGill University Canada (Quebec)
MAYO Mayo Clinic USA
MOD SQUAD Modifier Study of Quantitative Effects on Disease Czech Republic/Belgium
MSKCC Memorial Sloane Kettering Cancer Center USA
MUV General Hospital Vienna Austria
NCI National Cancer Institute USA
NICCC National Israeli Cancer Control Center Israel
NNPIO N.N. Petrov Institute of Oncology Russia
NORTHSHORE NorthShore University HealthSystem USA
OCGN Ontario Cancer Genetics Network Canada
OSU CCG The Ohio State University Comprehensive Cancer Center USA
OUH Odense University Hospital Denmark
PBCS Università di Pisa Italy
SEABASS South East Asian Breast Cancer Association Study Malaysia/Singapore
SMC Sheba Medical Centre Israel
SWE-BRCA Swedish Breast Cancer Study Sweden
UCHICAGO University of Chicago USA
UCLA University of California Los Angeles USA
UCSF University of California San Francisco USA
UKGRFOCR UK and Gilda Radner Familial Ovarian Cancer Registries UK/USA
UPENN University of Pennsylvania USA
UPITT Cancer Family Registry University of Pittsburg USA
UTMDACC University of Texas MD Anderson Cancer Center USA
VFCTG Victorian Familial Cancer Trials Group Australia
WCP Women's Cancer Program at Cedars-Sinai Medical Center USA

| CIMBA Home | About CIMBA | Eligibility | Projects | Publications | Study Groups | Contact | Meetings | Links | Members login | Return to Members